← Back to Clinical Trials
Recruiting NCT06457178

NCT06457178 Investigation of the Effect of Acceptance and Commitment Therapy-Based Intervention in Oncology Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06457178
Status Recruiting
Phase
Sponsor Istanbul University - Cerrahpasa
Condition Acceptance and Commitment Therapy
Study Type INTERVENTIONAL
Enrollment 75 participants
Start Date 2025-06-01
Primary Completion 2025-12-30

Trial Parameters

Condition Acceptance and Commitment Therapy
Sponsor Istanbul University - Cerrahpasa
Study Type INTERVENTIONAL
Phase N/A
Enrollment 75
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2025-06-01
Completion 2025-12-30
Interventions
Acceptance and Commitment Therapy-Based Intervention for Oncology PatientsPsychoeducation for Oncology Patients

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to investigate the effectiveness of Acceptance and Commitment Therapy Based Intervention for Oncology Patients. The main questions it aims to answer are: * Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of psychological distress? * Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of reintegration into normal life? Researchers will compare Acceptance and Commitment Therapy-Based Intervention for Oncology Patients (ACT) to Psychoeducation for Oncology Patients and routine care (with no specific intervention) to see if Acceptance and Commitment Therapy-Based Intervention for Oncology Patients is effective in psychological distress and reintegration into normal living.

Eligibility Criteria

Inclusion Criteria: * 18 years of age or older, * Being able to read and write, * Receiving oncologic treatment, * Being diagnosed with breast cancer, * To know about Medical Diagnosis, * Being in stage 1, 2 or 3 of the disease, * Receiving outpatient chemotherapy treatment only, * Internet access and computer skills to participate in online group interviews, * Low to moderate scores on the brief psychological resilience scale, Exclusion Criteria: * Having serious psychiatric or cognitive impairments that limit adherence to group sessions, * Having a physical disability that may make it difficult to participate in group sessions, * Failure to attend sessions regularly and absenteeism, * Currently being in a psychoeducation/psychotherapy group

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology